Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data

A major goal of cancer genome sequencing is to identify mutations or other somatic alterations that can be targeted by selective and specific drugs. dGene is an annotation tool designed to rapidly identify genes belonging to one of ten druggable classes that are frequently targeted in cancer drug development. These classes were comprehensively populated by combining and manually curating data from multiple specialized and general databases. dGene was used by The Cancer Genome Atlas squamous cell lung cancer project, and here we further demonstrate its utility using recently released breast cancer genome sequencing data. dGene is designed to be usable by any cancer researcher without the need for support from a bioinformatics specialist. A full description of dGene and options for its implementation are provided here.

[1]  Brad T. Sherman,et al.  DAVID gene ID conversion tool , 2008, Bioinformation.

[2]  S. Lampel,et al.  The druggable genome: an update. , 2005, Drug discovery today.

[3]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[4]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[5]  Hartmut Goldschmidt,et al.  Gene Expression Profiling and Real-Time PCR Analyses Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma1 , 2009, The Journal of Immunology.

[6]  Bas Vroling,et al.  NucleaRDB: information system for nuclear receptors , 2011, Nucleic Acids Res..

[7]  J. Cerhan,et al.  Genetic Variation in the Chromosome 17q23 Amplicon and Breast Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[8]  Bert Vogelstein,et al.  The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations , 2007, Science.

[9]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[10]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[11]  Joshua F. McMichael,et al.  Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition , 2012, Nature.

[12]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[13]  P. Rath,et al.  Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells , 2012, Molecular Biology Reports.

[14]  Bert Vogelstein,et al.  The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. , 2007, Science.

[15]  W. Kiess,et al.  Coexpression of insulin receptor-related receptor and insulin-like growth factor 1 receptor correlates with enhanced apoptosis and dedifferentiation in human neuroblastomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  N. Tonks,et al.  Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.

[17]  María Martín,et al.  The Gene Ontology: enhancements for 2011 , 2011, Nucleic Acids Res..

[18]  C. Downes,et al.  TPIP: a novel phosphoinositide 3-phosphatase. , 2001, The Biochemical journal.

[19]  The UniProt Consortium,et al.  Reorganizing the protein space at the Universal Protein Resource (UniProt) , 2011, Nucleic Acids Res..

[20]  G. Simon,et al.  Molecular targeted agents and biologic therapies for lung cancer. , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Neil D. Rawlings,et al.  MEROPS: the database of proteolytic enzymes, their substrates and inhibitors , 2013, Nucleic Acids Res..

[22]  J. Silberg,et al.  A transposase strategy for creating libraries of circularly permuted proteins , 2012, Nucleic acids research.

[23]  Robert L Strausberg,et al.  Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. , 2009, Translational oncology.

[24]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[25]  P. Rath,et al.  A Novel Human TPIP Splice-Variant (TPIP-C2) mRNA, Expressed in Human and Mouse Tissues, Strongly Inhibits Cell Growth in HeLa Cells , 2011, PloS one.

[26]  Joanna M. Sasin,et al.  Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.

[27]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.